Targeting miR-124 inhibits growth of prostate cancer xenografts and sensitized prostate cancer cells to anti-androgen

被引:0
|
作者
Shi, Xu-Bao [1 ]
Ma, Aihong [1 ]
Xue, Lingru [1 ]
White, Ralph W. deVere [1 ]
机构
[1] UC Davis Med Ctr, Sacramento, CA USA
关键词
D O I
10.1158/1538-7445.AM2014-4384
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4384
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Expression of miR-124 inhibits growth of medulloblastoma cells
    Silber, Joachim
    Hashizume, Rintaro
    Felix, Tristan
    Hariono, Sujatmi
    Yu, Mamie
    Berger, Mitchel S.
    Huse, Jason T.
    VandenBerg, Scott R.
    James, C. David
    Hodgson, J. Graeme
    Gupta, Nalin
    NEURO-ONCOLOGY, 2013, 15 (01) : 83 - 90
  • [32] miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
    Shi, Xu-Bao
    Ma, Ai-Hong
    Xue, Lingru
    Li, Meimei
    Nguyen, Hao G.
    Yang, Joy C.
    Tepper, Clifford G.
    Gandour-Edwards, Regina
    Evans, Christopher P.
    Kung, Hsing-Jien
    White, Ralph W. deVere
    CANCER RESEARCH, 2015, 75 (24) : 5309 - 5317
  • [33] Macrophages promote anti-androgen resistance in prostate cancer bone disease
    Li, Xue-Feng
    Selli, Cigdem
    Zhou, Han-Lin
    Cao, Jian
    Wu, Shuiqing
    Ma, Ruo-Yu
    Lu, Ye
    Zhang, Cheng-Bin
    Xun, Bijie
    Lam, Alyson D.
    Pang, Xiao-Cong
    Fernando, Anu
    Zhang, Zeda
    Unciti-Broceta, Asier
    Carragher, Neil O.
    Ramachandran, Prakash
    Henderson, Neil C.
    Sun, Ling-Ling
    Hu, Hai-Yan
    Li, Gui-Bo
    Sawyers, Charles
    Qian, Bin-Zhi
    JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (04):
  • [34] A new mechanism of estrogen action in prostate cancer: Inhibition of tissue androgen production and prostate cancer growth by Estradiol in androgen independent prostate cancer xenografts
    Montgomery, B.
    Nelson, P.
    Hess, D. L.
    Vessella, R.
    Corey, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Macrophage promotion of anti-androgen resistance in prostate cancer bone disease
    Li, Xue-Feng
    Selli, Cigdem
    Unciti-Broceta, Asier
    Carragher, Neil O.
    Hu, Hai-Yan
    Sawyers, Charles L.
    Qian, Bin-Zhi
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [36] EFFECT OF FLUTAMIDE, AN ANTI-ANDROGEN, ON STAGE-D CANCER OF THE PROSTATE
    KASSEM, NY
    NERI, RO
    MUNROE, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 256 - 256
  • [37] Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?
    Roach, M
    Reese, D
    Weinberg, V
    Small, EJ
    Carroll, PR
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 448 - 449
  • [38] Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
    Huang, Jian
    Lin, Biyun
    Li, Benyi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] EFFECTS OF ANTI-ANDROGEN THERAPY ON THE METASTATIC BEHAVIOR OF PROSTATE-CANCER
    HUTCHINS, GM
    DELAMONTE, SM
    MOORE, GW
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 600 - 600
  • [40] The effect on prostate volume of anti-androgen versus total androgen blockade in prostate cancer patients - a randomized study
    Majumder, K.
    Brandberg, Y.
    Johansson, H.
    Castellanos, E.
    Nilsson, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S485 - S485